Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$106,889,618
+$22,270,323 QoQ
Shares Held
4,155,895
-5.7% QoQ
Ownership
2.60%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#9
of 290 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 92%
Shared 1%
None 7%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Derivatives in DNLI
reported options exposure · as of Jun 30, 2021CallValue
$0
CallShares
0
PutValue
$2,353,200
PutShares
30,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,870 across 359 Biotechnology names. DNLI ranks #30 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in DNLI
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $106,889,618 | 4,155,895 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $84,619,295 | 4,407,255 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $63,329,105 | 3,835,803 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $31,416,995 | 2,163,705 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $26,095,882 | 1,865,324 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $22,731,899 | 1,672,078 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $21,552,318 | 1,057,523 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $39,844,624 | 1,367,821 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $28,303,437 | 1,218,925 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $18,557,487 | 904,361 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,451,054 | 393,805 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $8,404,516 | 407,393 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $19,031,411 | 644,914 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $13,198,301 | 572,843 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $21,454,078 | 771,452 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $22,350,667 | 728,272 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $13,068,353 | 406,228 | Shares | Defined | 2022-05-16 | |
| 2021-06-30 | $46,108,443 | 587,818 | Shares | Defined | 2021-08-13 | |
| 2021-06-30 | $2,353,200 | 30,000 | Put | Defined | 2021-08-13 | |
| 2021-03-31 | $36,992,291 | 647,851 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $58,832,521 | 702,394 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $18,113,569 | 505,542 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,508,420 | 227,809 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,300,201 | 131,365 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||